Ursodiol and Mirabegron drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ursodiol (ursodiol) and Mirabegron (mirabegron). Common drug interactions include cardiac failure among females and glomerulonephritis rapidly progressive among males.
The phase IV clinical study analyzes what interactions people have when they take Ursodiol and Mirabegron. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.
What is Ursodiol?
Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.
What is Mirabegron?
Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.
66 people who take Ursodiol and Mirabegron together, and have interactions are studied.

What are the common drug interactions of Ursodiol and Mirabegron, by gender? *:
female:
- Cardiac failure
- Chest pain
- Cholecystitis (infection of gallbladder)
- Depressed mood
- Enterocele (hernia of the intestine through the vagina)
- Gallbladder disorder
- Gingival bleeding (bleeding gums)
- Gingival blister (ulcer in blister)
- Gingival erosion (gum ulcer)
- Diarrhoea
male:
- Glomerulonephritis rapidly progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function)
- Microscopic polyangiitis (inflammation involving multiple blood or lymph small-vessel)
- Vomiting
- Cholecystitis chronic (long lasting infection of gallbladder)
- Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
- Drug ineffective
- Erythema (redness of the skin)
- Pneumonia cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses)
- Blindness
- Diarrhoea
What are the common drug interactions of Ursodiol and Mirabegron, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Diabetes mellitus inadequate control
- Fungal infection
- Infection
- Oropharyngeal pain
- Altered state of consciousness (altered state of mind)
- Colitis (inflammation of colon)
- Dizziness
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Dyspnoea (difficult or laboured respiration)
- Hallucination (an experience involving the perception of something not present)
60+:
- Vomiting
- Diarrhoea
- Gastric ulcer (stomach ulcer)
- Gastric varices
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Headache (pain in head)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Oedema (fluid collection in tissue)
- Body temperature increased
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
What are the existing conditions these people have? *
- High Blood Pressure: 19 people, 28.79%
- Nausea (feeling of having an urge to vomit): 13 people, 19.70%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 12 people, 18.18%
- Dyslipidaemia (abnormal amount of lipids): 11 people, 16.67%
- Enlarged Prostate: 11 people, 16.67%
- Haemoglobin Decreased: 10 people, 15.15%
- Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 10 people, 15.15%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 15.15%
- Pain: 10 people, 15.15%
- Gallstones (stone formation by bile component): 10 people, 15.15%
* Approximation only. Some reports may have incomplete information.
Do you take Ursodiol and Mirabegron?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ursodiol (19,061 reports)
- Mirabegron (5,414 reports)
Browse all drug interactions of Ursodiol and Mirabegron:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ursodiol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mirabegron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ursodiol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mirabegron and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ursodiol and mirabegron (the active ingredients of Ursodiol and Mirabegron, respectively), and Ursodiol and Mirabegron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Valproic Acid and Bricanyl - 3 seconds ago
- Focal Segmental Glomerulosclerosis and Anaemia - 8 seconds ago
- Could Librium cause Disseminated Intravascular Coagulation? - 12 seconds ago
- Ziana vs. Septra, side effect and effectiveness comparison - 14 seconds ago
- Could Coumadin cause Asphyxia? - 18 seconds ago
- Drug interactions of Arava and Bifido - 18 seconds ago
- Could Gabapentin cause Fluid Retention? - 23 seconds ago
- Could Tegretol cause Femoral Neck Fracture? - 26 seconds ago
- Drug interactions of Lisinopril and Buspirone Hydrochloride - 29 seconds ago
- Idiopathic Thrombocytopenic Purpura and Nosebleed - 39 seconds ago